Future Supply. Commencing on the Manufacturing Transition Date and subject to the terms and conditions contained in this Agreement, GSK agrees to purchase solely from Antigenics MA or its Affiliates (or a Third Party manufacturer approved by GSK, such approval not to be unreasonably withheld or delayed), and Antigenics MA (itself or through an Affiliate or a Third Party manufacturer approved by GSK, such approval not to be unreasonably withheld or delayed) retains the right and has the obligation, to Manufacture, [**] percent [**] of GSK’s and its Affiliates and, if requested by GSK in accordance with this Agreement, Third Party Sublicensees’ requirements of QS-21 (subject to the Manufacturing Capacity) for use solely in the development, marketing and sale of QS-21 Vaccines in the Territory, up to [**] per year for three (3) years after the Manufacturing Transition Date. In the event that GSK’s requirements for QS-21 exceed [**] per year during such three year period, the Parties will discuss in good faith the potential for increasing the [**] cap hereunder. Beyond that period, at either Party’s request, the Parties will discuss in good faith, the possibility of extending the QS-21 supply by Antigenics MA to GSK.
Future Supply. 8.1 Service Area This agreement between the City and the Customer is to supply water to the Customer’s existing industrial operations and/or water service area. In this regard, the Customer agrees not to increase its industrial operations, to add new customers, or to expand its service area in a manner that would increase its water requirements by more than 10 percent without the prior approval of the City.
Future Supply. If any Specific Development Project undertaken in connection with the Development Program results in the development of one or more commercially viable Nanomaterials, the parties will enter into a supply agreement (the “Supply Agreement”) having an initial term of at least three (3) years and a price at or within ten percent (10%) of the Target Price and customary terms, including those set forth in Exhibit B hereto.
Future Supply. Promptly after the Effective Date, Millennium and GSK will meet to discuss in good faith options for [**] the Licensed Product for the Territory, including the [**] for the Territory [**] of the Supply Agreement. The Parties will [**] pursuant to this Section 6.3(b) [**] pursuant to which GSK will purchase [**] (either supply agreement, the "Future Supply Agreement").
Future Supply. Stryker agrees that, prior to June 30, 1999, Stryker shall manufacture for Creative 15 grams of OP-1, which OP-1 shall be manufactured in accordance with specifications identical to those applied to the OP-1 delivered to Stryker hereunder. Creative may decrease the amount of OP-1 to be supplied hereunder on or before March 31, 1999. Such OP-1 shall be delivered to Creative at a time or times selected by Creative during the period from June 30, 1999 through and including December 31, 1999, and shall be sold to Creative at a price of [XXXXX] per milligram.
